Theravance Biopharma DPO Ratio | TBPH

Annual DPO Ratio Theravance Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	4.61 K	359	219	1.47 K	892	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
4.61 K	219	1.51 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Dynavax Technologies Corporation DVAX	52.8	-	-	$ 2.02 B	USA
I-Mab IMAB	4.85 K	-	-	$ 866 M	China
AgeX Therapeutics AGE	5.24 K	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Qilian International Holding Group Limited QLI	61.7	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	47.4	-	1.35 %	$ 17.8 M	China
Завод ДИОД DIOD	30.3	-	-	-	Russia
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Codexis CDXS	85.8	$ 1.46	2.82 %	$ 127 M	USA
Ardelyx ARDX	163	$ 3.78	1.89 %	$ 911 M	USA
Affimed N.V. AFMD	2.52 K	-	-34.95 %	$ 21.5 M	Germany
Arcutis Biotherapeutics ARQT	133	$ 23.9	1.01 %	$ 3.04 B	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	238	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	55.8 K	-	-	$ 12.5 M	Belgium
Cyclacel Pharmaceuticals CYCCP	1.79 K	-	-4.36 %	$ 27 M	USA
Axsome Therapeutics AXSM	529	$ 206.68	0.16 %	$ 10.3 B	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	245	$ 66.53	0.15 %	$ 12.8 B	USA
BeiGene, Ltd. BGNE	355	-	0.49 %	$ 251 B	Cayman-islands
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
ChromaDex Corporation CDXC	76.3	-	-0.88 %	$ 598 M	USA